Featured Publications
The Vascular Quality Initiative assessment of the Bard Lifestent for the treatment of popliteal artery occlusive disease
Bertges D, Eldrup-Jorgensen J, Eskandari M, Hamdan A, Mena-Hurtado C, Mewissen M, Smith T, Woo E, Cronenwett J, Initiative S. The Vascular Quality Initiative assessment of the Bard Lifestent for the treatment of popliteal artery occlusive disease. Journal Of Vascular Surgery 2023, 78: 1489-1496.e1. PMID: 37648091, DOI: 10.1016/j.jvs.2023.08.122.Peer-Reviewed Original ResearchConceptsTarget lesion revascularizationChronic limb-threatening ischemiaTarget vessel revascularizationMajor adverse eventsLimb-threatening ischemiaPopliteal arteryLesion revascularizationMajor amputationVessel revascularizationHemodynamic successSecondary patencyAdverse eventsOcclusive diseaseProcedural successSingle-arm prospective studyProximal popliteal arterySustained clinical successPrimary efficacy outcomePrimary safety outcomeArtery occlusive diseaseComposite primary endpointPrimary-assisted patencyKaplan-Meier analysisSuperficial femoral arteryMajority of stents
2020
Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease Meta-Analysis of Randomized Trials
Atti V, Gwon Y, Narayanan MA, Garcia S, Sandoval Y, Brilakis ES, Basir MB, Turagam MK, Khandelwal A, Mena-Hurtado C, Mamas MA, Abbott JD, Bhatt DL, Velagapudi P. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease Meta-Analysis of Randomized Trials. JACC Cardiovascular Interventions 2020, 13: 1571-1582. PMID: 32646699, DOI: 10.1016/j.jcin.2020.04.055.Peer-Reviewed Original ResearchConceptsMultivessel percutaneous coronary interventionST-segment elevation myocardial infarctionPercutaneous coronary interventionElevation myocardial infarctionMultivessel coronary artery diseaseCulprit vesselCoronary artery diseaseCause mortalityMyocardial infarctionArtery diseaseControlled TrialsRisk ratioLower riskUnderwent multivessel PCIVersus Culprit-Only RevascularizationCulprit-only revascularizationMultivessel PCI strategyPrimary efficacy outcomeCochrane Central RegisterContrast-induced nephropathyConfidence intervalsRandom-effects modelWeb of ScienceMajor bleedingCardiovascular mortality